MICHAEL A TAYLOR, MD
Psychiatric in Ann Arbor, MI

License number
Michigan 4301067307
Category
Psychiatric
Type
Psychiatry
Address
Address
1500 Floor University Hospital Recp D, Ann Arbor, MI 48109
Phone
(734) 764-5348
(734) 936-2047

Personal information

See more information about MICHAEL A TAYLOR at radaris.com
Name
Address
Phone
Michael Taylor
49975 Helfer Blvd, Wixom, MI 48393
Michael Taylor
49800 Pointe Xing, Plymouth, MI 48170
(734) 731-4134
Michael Taylor, age 62
4949 Windham Dr, Sterling Heights, MI 48310
(586) 978-9798
Michael Taylor
4801 Duvernay Dr APT 312, Lansing, MI 48910
Michael Taylor, age 61
4837 Aviemore Dr, Sterling Heights, MI 48314
(586) 726-5519

Organization information

See more information about MICHAEL A TAYLOR at bizstanding.com

Michael Taylor MD

1500 E Medical Ctr Dr, Ann Arbor, MI 48109

Industry:
Psychiatrist
Phone:
(734) 764-5348 (Phone)
Michael Alan Taylor

Professional information

Michael Taylor Photo 1

Financial Analyst At Ford Motor Company

Position:
Financial Analyst at Ford Motor Company
Location:
Greater Detroit Area
Industry:
Accounting
Work:
Ford Motor Company - Dearborn, MI since Jun 2010 - Financial Analyst Ford Motor Company - Dearborn, MI May 2009 - Aug 2009 - Accounting Internship Adaptive Materials Inc. - Ann Arbor, MI Oct 2007 - Sep 2008 - Staff Accountant University of Michigan Health System - Ann Arbor, MI Dec 2003 - Jul 2007 - Purchasing Clerk
Education:
Eastern Michigan University 2008 - 2010
MSA, Accounting
University of Michigan 1998 - 2002
B.S., Environmental Science - Transportation & Energy
Honor & Awards:
Beta Alpha Psi - Award winning presentation on Fraud in Detroit Public Schools
Languages:
Spanish


Michael Taylor Photo 2

Michael Taylor - Ann Arbor, MI

Work:
International Transmission Company (ITC)
Senior Economic Analyst
Professional Publications and Speaking Engagements Federal Energy Regulatory Commission
Regulatory Analyst
Graduate Student Instructor US Dept. of Energy - Energy Information Administration (EIA) - Washington, DC
Economist Intern
Beztak Real Estate Development Co - Farmington Hills, MI
Financial Analyst
Education:
University of Michigan Ann Arbor - Ann Arbor, MI
Master of Arts in Statistics
University of Michigan Ann Arbor - Ann Arbor, MI
Master of Science in Science and Engineering


Michael A Taylor Photo 3

Dr. Michael A Taylor, Ann Arbor MI - MD (Doctor of Medicine)

Specialties:
Psychiatry, Neuropsychiatry (Psychiatry)
Address:
1500 E Medical Center Dr SUITE 8TH, Ann Arbor 48109
(734) 764-5348 (Phone), (734) 615-2514 (Fax)
UNIVERSITY MICHIGAN SYSTEMS
1500 E Medical Center Dr SUITE 9C, Ann Arbor 48109
(800) 525-5188 (Phone), (734) 936-9983 (Fax)
MICHIGAN SURGICAL ASSOC
22646 E 9 Mile Rd SUITE C, Saint Clair Shores 48080
(586) 443-5400 (Phone), (586) 443-5403 (Fax)
Certifications:
Psychiatry, 1972
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1500 E Medical Center Dr SUITE 8TH, Ann Arbor 48109
UNIVERSITY MICHIGAN SYSTEMS
1500 E Medical Center Dr SUITE 9C, Ann Arbor 48109
MICHIGAN SURGICAL ASSOC
22646 E 9 Mile Rd SUITE C, Saint Clair Shores 48080
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
New York Medical College
Graduated: 1965
Lenox Hill Hosp


Michael Taylor Photo 4

Michael Taylor, Ann Arbor MI

Specialties:
Psychiatry, Pediatrics
Work:
Va Ann Arbor Healthcare System
2215 Fuller Rd, Ann Arbor, MI 48105 University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
New York Medical College (1965)


Michael Taylor Photo 5

Methods Of Using Endothelin Antagonists

US Patent:
5641752, Jun 24, 1997
Filed:
Sep 30, 1994
Appl. No.:
8/316533
Inventors:
Wayne Livingston Cody - Saline MI
Patricia DePue - Canton MI
Annette Marian Doherty - Ann Arbor MI
John Xiaoqiang He - Ypsilanti MI
Michael Douglas Taylor - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 3800, C07K 500, C07K 700
US Classification:
514 17
Abstract:
Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.


Michael Taylor Photo 6

Imidazo-Pyridine Angiotensin Ii Antagonists Used To Treat Memory Loss

US Patent:
5444069, Aug 22, 1995
Filed:
Apr 13, 1994
Appl. No.:
8/227223
Inventors:
David T. Dudley - Ann Arbor MI
John C. Hodges - Ann Arbor MI
Thomas A. Pugsley - Ann Arbor MI
Michael D. Taylor - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31415, A61K 3134
US Classification:
514303
Abstract:
The present invention relates to the use of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acids and analogs thereof in antagonizing the binding of angiotensin II to AT. sub. 2 receptors to treat memory loss.


Michael Taylor Photo 7

2-Alkylidene Derivatives Of 1,2,3,4-Tetrahydropyridine-2,5-Pyridine Carboxylic Acid Dialkyl Esters Useful For Treatment Of Cardiovascular Disorders

US Patent:
4678796, Jul 7, 1987
Filed:
Sep 3, 1986
Appl. No.:
6/903882
Inventors:
Michael D. Taylor - Ann Arbor MI
Edward W. Badger - Dexter MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
C07D21190, C07D40112, C07D40512, A61K 31455
US Classification:
514356
Abstract:
Novel 2-(2-alkoxy-2-oxoethylidene)-1,2,3,4-tetrahydro-6-methyl-4-[2-(substituted )phenyl]-3,5-pyridinedicarboxylic acid dialkyl ester derivatives having novel inotropic and hypotensive activity, processes for their manufacture, pharmaceutical compositions, and methods for using said compounds and compositions are described.


Michael Taylor Photo 8

Angiotensin Ii Antagonists Used To Treat Reproductive Functions Associated With At.sub.2 Receptors

US Patent:
5338744, Aug 16, 1994
Filed:
Aug 19, 1992
Appl. No.:
7/932167
Inventors:
David T. Dudley - Ann Arbor MI
John C. Hodges - Ann Arbor MI
Thomas A. Pugsley - Ann Arbor MI
Michael D. Taylor - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31415, A61K 3134
US Classification:
514303
Abstract:
The present invention relates to the use of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acids and analogs thereof in antagonizing the binding of angiotensin II to AT. sub. 2 receptors.


Michael Taylor Photo 9

2-(2-Aryl-2-Oxoalkylidene) Analogs Of-3,5-Pyridinedicarboxylic Acid Dialkyl Esters Useful For Treatment Of Cardiovascular Disorders

US Patent:
4732898, Mar 22, 1988
Filed:
Mar 3, 1987
Appl. No.:
7/016896
Inventors:
Edward W. Badger - Dexter MI
Michael D. Taylor - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 31455, C07D21190, C07D40106, C07D21554
US Classification:
514225
Abstract:
The present invention are 2-(2-aryl-2-oxo-alkylidene) analogs of 1,2,3,4-tetrahydropyridine-3,5-pyridinecarboxylic acids and particularly esters thereof having valuable calcium antagonist and positive inotropic activity useful in the treatment of cardiovascular disorders, pharmaceutical compositions and methods of use therefor.


Michael Taylor Photo 10

Endothelin Antagonists

US Patent:
5773414, Jun 30, 1998
Filed:
Mar 7, 1997
Appl. No.:
8/813625
Inventors:
Wayne Livingston Cody - Saline MI
Patricia DePue - Canton MI
Annette Marian Doherty - Ann Arbor MI
John Xiaoqiang He - Ypsilanti MI
Michael Douglas Taylor - Ann Arbor MI
Assignee:
Warner-Lambert Company - Morris Plains NJ
International Classification:
A61K 3800, A61K 3802, C07K 500, C07K 700
US Classification:
514 17
Abstract:
Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, Raynaud's disease, percutaneous transluminal coronary angioplasty or restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, ischemic bowel disease, and diabetes.